ProMIS Financial Statements From 2010 to 2025

PMN Stock  USD 0.71  0.03  4.05%   
ProMIS Neurosciences financial statements provide useful quarterly and yearly information to potential ProMIS Neurosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ProMIS Neurosciences financial statements helps investors assess ProMIS Neurosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ProMIS Neurosciences' valuation are summarized below:
Gross Profit
-8.5 M
Market Capitalization
23.2 M
Enterprise Value Revenue
3.9 K
Revenue
7.6 K
Earnings Share
0.04
We have found one hundred twenty available trending fundamental ratios for ProMIS Neurosciences, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to check out ProMIS Neurosciences' recent fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 2nd of March 2025, Market Cap is likely to grow to about 24.5 M, though Enterprise Value is likely to grow to (2.8 M).

ProMIS Neurosciences Total Revenue

0.0

Check ProMIS Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ProMIS Neurosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 46.1 K, Total Revenue of 0.0 or Other Operating Expenses of 22.8 M, as well as many indicators such as Price To Sales Ratio of 5.1 K, Dividend Yield of 0.0 or PTB Ratio of 3.11. ProMIS financial statements analysis is a perfect complement when working with ProMIS Neurosciences Valuation or Volatility modules.
  
Check out the analysis of ProMIS Neurosciences Correlation against competitors.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.

ProMIS Neurosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets21.8 M20.8 M6.9 M
Slightly volatile
Total Current Liabilities15 M14.2 M3.9 M
Slightly volatile
Accounts Payable12.5 M12 M2.7 M
Slightly volatile
Cash20.2 M19.2 M5.9 M
Slightly volatile
Non Current Assets Total24.5 K25.8 K66.8 K
Slightly volatile
Cash And Short Term Investments20.2 M19.3 M6.3 M
Slightly volatile
Net Receivables110.2 K64.5 K53.8 K
Slightly volatile
Common Stock Shares Outstanding14.8 M14.1 MM
Slightly volatile
Short Term Investments52.7 K55.5 K330.4 K
Slightly volatile
Liabilities And Stockholders Equity21 M20 M6.6 M
Slightly volatile
Non Current Liabilities Total747.2 K786.5 K1.5 M
Pretty Stable
Other Current Assets1.6 M1.5 M505.3 K
Slightly volatile
Other Stockholder Equity156.1 M148.7 M45.3 M
Slightly volatile
Total Liabilities15.8 M15 M4.9 M
Slightly volatile
Total Current Assets21.8 M20.8 M6.8 M
Slightly volatile
Intangible Assets43.6 K25.4 K55 K
Slightly volatile
Common Stock38.3 M65 M39.4 M
Slightly volatile
Current Deferred Revenue133 K149.6 K163.1 K
Slightly volatile
Short and Long Term Debt TotalM5.7 M2.9 M
Slightly volatile
Short Term Debt131.5 K139 K121.7 K
Slightly volatile
Property Plant Equipment27428914 K
Pretty Stable
Property Plant And Equipment Gross80.4 K72.3 K82.2 K
Pretty Stable
Other Liabilities1.6 M1.7 M7.1 M
Slightly volatile
Long Term Debt3.1 M3.5 M3.8 M
Slightly volatile

ProMIS Neurosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization46.1 K25.2 K22.2 K
Very volatile
Other Operating Expenses22.8 M21.7 M8.2 M
Slightly volatile
Research Development9.5 M9.1 M4.4 M
Slightly volatile
Total Operating Expenses6.1 M9.7 M5.8 M
Slightly volatile
Selling General Administrative8.9 M8.5 MM
Slightly volatile
Reconciled Depreciation5.1 K5.4 K8.4 K
Pretty Stable
Interest Income5.7 K5.4 K1.7 K
Slightly volatile
Cost Of Revenue11.3 M12 MM
Slightly volatile

ProMIS Neurosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow9.6 M9.1 M3.3 M
Slightly volatile
Other Cashflows From Financing Activities25.7 M27 M411.3 M
Pretty Stable
Depreciation25.5 M24.3 M4.5 M
Slightly volatile
Total Cash From Financing Activities28.4 M27 M9.1 M
Slightly volatile
End Period Cash Flow20.2 M19.2 M5.4 M
Slightly volatile
Stock Based Compensation327.9 M312.3 M57.4 M
Slightly volatile
Net BorrowingsM7.8 M8.5 M
Slightly volatile
Issuance Of Capital Stock28.1 M26.7 M9.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.1 K5.3 K18.9 K
Very volatile
Days Sales Outstanding1.922.02476
Slightly volatile
Invested Capital592.2 K623.4 K14.8 M
Slightly volatile
Average Payables6.3 MM1.6 M
Slightly volatile
Stock Based Compensation To Revenue54.1757.02225
Very volatile
Capex To Depreciation0.190.24.0502
Slightly volatile
EV To Sales3.3 K3.5 K17.7 K
Very volatile
Payables Turnover1.11.1610.3242
Slightly volatile
Sales General And Administrative To Revenue348366767
Pretty Stable
Research And Ddevelopement To Revenue5205471.6 K
Pretty Stable
Capex To Revenue0.630.6730.7944
Pretty Stable
Cash Per Share1.491.571.6668
Pretty Stable
Days Payables Outstanding34332789.5675
Slightly volatile
Net Current Asset Value519583636
Slightly volatile
Income Quality0.660.740.8235
Pretty Stable
Tangible Asset Value567638696
Slightly volatile
Intangibles To Total Assets0.00330.00350.0734
Slightly volatile
Net Debt To EBITDA0.890.840.4528
Slightly volatile
Current Ratio1.591.683.7277
Pretty Stable
Receivables Turnover178187167
Slightly volatile
Graham Number3.934.145.6033
Slightly volatile
Debt To Equity0.70.620.5671
Slightly volatile
Capex Per Share3.0E-43.0E-40.0256
Slightly volatile
Average Receivables186.4 K183.7 K167.8 K
Very volatile
Revenue Per Share0.00150.00160.0259
Slightly volatile
Debt To Assets0.120.20.1626
Slightly volatile
Days Of Payables Outstanding34332789.5675
Slightly volatile
Ebt Per Ebit1.081.071.0078
Very volatile
Long Term Debt To Capitalization0.330.370.401
Slightly volatile
Total Debt To Capitalization0.320.370.3232
Slightly volatile
Debt Equity Ratio0.70.620.5671
Slightly volatile
Quick Ratio1.591.683.7532
Pretty Stable
Net Income Per E B T1.010.810.9576
Slightly volatile
Cash Ratio1.611.212.0894
Pretty Stable
Days Of Sales Outstanding1.922.02476
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.151.0341
Slightly volatile
Fixed Asset Turnover1.511.583.4611
Slightly volatile
Debt Ratio0.120.20.1626
Slightly volatile
Price Sales Ratio5.1 K5.3 K18.9 K
Very volatile
Asset Turnover4.0E-44.0E-40.0583
Slightly volatile

ProMIS Neurosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap24.5 M12.7 M27.3 M
Pretty Stable
Working Capital519583636
Slightly volatile

ProMIS Fundamental Market Drivers

Cash And Short Term Investments16.8 M

ProMIS Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About ProMIS Neurosciences Financial Statements

ProMIS Neurosciences investors utilize fundamental indicators, such as revenue or net income, to predict how ProMIS Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue149.6 K133 K
Cost Of Revenue12 M11.3 M
Stock Based Compensation To Revenue 57.02  54.17 
Sales General And Administrative To Revenue 366.40  348.08 
Research And Ddevelopement To Revenue 547.29  519.93 
Capex To Revenue 0.67  0.63 
Ebit Per Revenue-1.2 K-1.2 K

Pair Trading with ProMIS Neurosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProMIS Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will appreciate offsetting losses from the drop in the long position's value.

Moving against ProMIS Stock

  0.45FENC Fennec PharmaceuticalsPairCorr
The ability to find closely correlated positions to ProMIS Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProMIS Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProMIS Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProMIS Neurosciences to buy it.
The correlation of ProMIS Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProMIS Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProMIS Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProMIS Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether ProMIS Neurosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProMIS Neurosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Promis Neurosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Promis Neurosciences Stock:
Check out the analysis of ProMIS Neurosciences Correlation against competitors.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.04
Revenue Per Share
0.001
Return On Assets
(0.43)
Return On Equity
(0.08)
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.